Microbiome Yarns: The Global Phenotype-Genotype
Survey: Episode I: all my worldly goods, including my microbiome, I thee endow by Timmis, Kenneth N. et al.
doi:10.1111/1751-7915.13341
Editorial
Microbiome yarns: The Global Phenotype-Genotype
Survey
Episode I: all my worldly goods, including my microbiome,
I thee endow
Kenneth Timmis,1 Franziska Jebok,2 Manfred Rohde3
and Gabriella Molinari3
1Institute of Microbiology, Technical University
Braunschweig, Braunschweig, Germany.
2Institute for Educational Science, University of Freiburg,
Freiburg, Germany.
3Central Facility for Microscopy, Helmholtz Centre for
Infection Research, Braunschweig, Germany.
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Abigail Repor-Tastory5, Discovery Presenter, turns to
face the camera:
I, Jack, take you, Jill, to be my wife, to have and to hold
from this day forward; for better, for worse, for richer, for
poorer, in sickness and in health, to love and to cherish;
till death do us part.”. . .. . ...” With this ring I thee wed,
with my body I thee worship, and with all my worldly
goods I thee endow. Well, except for those listed in our
prenup6.
Good evening viewers and welcome to a new episode of
‘Discoveries that Change our Lives’. Our guest this eve-
ning is once again Dr. Anastasia Noitall-Most5 from the
Streber Elite University of Los Angeles5. Good evening
Dr. Noitall-Most (shaking hands) and thank you for
appearing on the programme.
Dr. Noitall-Most: Good evening Abi; always a pleasure to
be here.
Ms. Repor-Tastory: Ani, this evening we will discuss the
results of the most ambitious human microbiome survey
to date, and some subsequent trials designed to assess
whether or not the correlations it uncovered reflect
causalities. AND: we will discuss how couples intending
to tie the knot are dealing with the knotty (sorry!) prob-
lem of who owns what in terms of their microbiomes.
Dr. Noitall-Most: Yes, Abi: this is indeed a perplexing
issue that lawyers are cannily turning into a significant
new revenue stream. But before we get into this, we
need to inform viewers about recent commercial devel-
opments in the field of microbiome science, in order to
provide important background.
As many of our viewers will have heard via social media,
recent estimates of the number of microbes on and in
our bodies suggest that humans are 50% microbial, that
is: microbes constitute 50% of all cells that we consist
of7. And, of course, our microbial half doesn’t just sit
there and enjoy being ferried around and fed by the
other half; it influences and even controls to a significant
extent our behaviour, well-being and health status. In
particular, the gastro-intestinal microbiota, which indeed
makes up the major part of the microbial 50%, is cen-
trally involved in immune system development and func-
tioning8, and inflammatory responses, including those
mediating food sensitivities9, has a profound influence
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on brain activity and mental well-being, via the so-called
gut:brain axis10, and may be involved in the functioning
of other organs, via the gut:skin axis11, the gut:lung
axis12, the gut:liver axis13, the gut:skeleton axis14, etc.
This web of modulatory buttons are pushed in part via
microbe:host cell interactions, and in part via some of
the enormous spectrum of metabolites produced by gut
microbes15, which are absorbed by the intestine and dis-
tributed via the vascular system. Such metabolites may
act directly on body processes16, or indirectly, by acting
as regulatory hormones17; indeed, the gut microbiota is
now considered to constitute our second endocrine sys-
tem17. In particular, short chain fatty acids produced from
our food intake by the gut microbiota seem to play a key
role in some processes16,17.
Ms. Repor-Tastory: Yes, Ani: bodily functions we have
always considered as peculiarly human, like weight gain
tendency, hormonal control and imbalance, mental well-
being, etc., are now being attributed, at least in part, to
our microbial friends!
Dr. Noitall-Most: Another pivotal finding is that our micro-
bial 50% varies from individual to individual18, so per-
sonal differences are to some extent microbially
mediated. And, importantly for this evening, a number of
things we do during the course of the day (and more so
at night, and on birthdays) result in the sharing of bits
and pieces of our microbiome with others. So: a key
question occupying microbiomologists right now is
whether or not our personal characteristics may change
as a result of acquiring microbiota from others.
Ms. Repor-Tastory: Yes, Ani: since the start of this pro-
gramme series about our microbiomes, I often wonder
which new microbial friends I am acquiring when loung-
ing in the hot tubs of new acquaintances, drinking a
G&T!
Dr. Noitall-Most: Well, you jest, but there have been
quite a few publications on infections acquired from hot
tubs19, some not so pleasant, and there are even dis-
eases called hot tub lung and hot tub folliculitis19. Of
course, most clean and properly maintained hot tubs do
keep down the microbiota we shed into them. BUT, inad-
equately maintained hot tubs, and indeed other incor-
rectly managed recreational waters, allow survival and
sometimes growth of microbes, including some in the
microbiota bounties we shed while relaxing or engaged
in sporting activities, and can be a means of microbiota
exchange, and of course a source of infections19.
Ms. Repor-Tastory: Gosh: I really will have to be more
circumspect about accepting late afternoon hot tub G&T
invitations in future!
Dr. Noitall-Most: Quite so: new lifestyle fads often come
with unanticipated risks! Anyway, to return to the issue
of economic and legal aspects of microbiota sharing, we
all know by now that a number of clinical conditions
caused either by pathogenic microbes or an unhealthy
microbial flora, or to use the current technical term dys-
biosis20, have been successfully treated by transplants
of ‘healthy’ or ‘normal’ microbial communities obtained
from donors. The, by now, classical example is the cur-
ing by faecal transplants of colitis caused by Clostridium
difficile21 Moreover, conditions like obesity22 and dia-
betes23 have been linked with specific gut microbial con-
stellations and functionalities, and new correlations are
emerging with regularity. These findings have fuelled an
explosion of start-up companies exploring the potential
application of microbiota transplants to cure or amelio-
rate all sorts of conditions.
Ms. Repor-Tastory: Presumably, it won’t be long before
all animals and plants24 of interest and importance to us
will be subjected to microbiomological scrutiny, in order
to explore transplant opportunities in prevention, therapy
and health robustness?
Dr. Noitall-Most: Most certainly! But, to return to humans,
in order to be able to treat the growing number of patients,
and to enable the growing number of properly controlled
trials, there is an enormous demand for carefully charac-
terized and conserved microbiota samples from diverse
donors that have been properly collected and stored25.
Now while this may seem to be purely a logistical and
standardization issue, there exists considerable uncer-
tainty as to what samples are needed. The problems
with microbiota samples from donors is that they differ
significantly from person to person, and even over time
from the same donor, so reproducibility and quality con-
trol are challenges, and the potential for transmission of
any pathogens in the samples is not negligible. For this
reason, there have been great efforts to create simple
synthetic microbiota mixes from isolated and character-
ized individual strains thought to be functionally critical
for transplants26. However, the big question is: will single
strains, or even simple artificial mixes of such strains, be
as effective as the highly complex natural microbiota?
Until recently, we did not know and it was not unlikely
that some conditions may be effectively treated by single
strains, and some by synthetic mixes, whereas others
would require natural microbiota. For this reason, many
transplant companies have been developing all types in
parallel.
Ms. Repor-Tastory: Yes, I read somewhere that there is
a rapidly growing amount of corporate debt
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accumulating, as a result of all the transplant cocktails
being formulated and trials being undertaken.
Dr. Noitall-Most: Which is a bit of a worry for those of us
invested in such companies. . ...Anyway, this brings us to
the issue of keystone microbes. A keystone is an organ-
ism that plays a key role in determining the composition
and functioning of an ecosystem or, in our case, the
microbiome part of the human biome and how it determi-
nes our well-being27 If a particular human disease or
characteristic is influenced by a single organism, then in
principle its treatment or modification becomes a great
deal simpler than those caused by complex microbial
constellations. So there is a lot of interest in whether or
not keystone microbes are involved in any human
characteristics.
A second issue is: are natural microbiota, including pos-
sible keystone microbes, from some donors better than
those from others? In other words, will blue blood Adonis
Kingman’s and Venus Empressa’s microbiota contain
better microbes, and therefore have a higher intrinsic
commercial value, than those from reddish blood Maude
Cobbler and Dennis Winterbottom? Of course, we know
from biotechnology that some microbial strains are better
than others belonging to the same species at producing
a particular drug or enzyme that carries out an interest-
ing reaction. So, if this, as seems likely, turns out to be
the case for certain microbiota constellations, and espe-
cially for keystones, this may mean that specific bugs in
some people’s microbiome may also be superior for the
creation of synthetic mixes. So: there is a lot of effort to
determine if Adonis’ and Venus’ microbiomes are indeed
superior sources of microbes for transplantation than
those of Maude and Dennis and, if so, to commercialize
them and the relevant individual strains. An amazing
number of start-ups and, especially some of the largest
pharma-food-personal care-data processing tech-partner
search companies have formed intricate strategic alli-
ances to develop and market diverse clinical and per-
sonal care microbiota products.
Ms. Repor-Tastory: Wow: yes, I always wondered
whether blue bloods have inherent superior genes, now
also microbiomes, or whether they are like everyone
else and just had the luck to be born into a dynasty!
Dr. Noitall-Most: Indeed: I think a quite a few folk have
pondered this question, especially the blue bloods them-
selves! Anyway, as you will recall, to obtain some
answers to these and other burning questions, the most
ambitious microbiome survey to date, the Global Pheno-
type-Genotype Survey, was carried out by an interna-
tional research group assembled by a global consortium
of health agencies, in order to confirm existing
correlations of influences of microbiota on phenotypes,
and to discover new ones. Let’s just listen in to the sum-
mary of its findings, presented a year ago by Professor
Phichit28 Dubbelblindangeentee, Coordinator, Global
Microbiome Assessment Unit, addressing a session of
senior public health officials, directors of microbiome
institutes, and heads of diverse NGOs, at the World
Biome Health Organisation in Geneva.
Camera switch from studio to video:
Professor Dubbelblindangeentee: Good morning! It gives
me much pleasure to share with you, the policy-making
and decision-taking international health professionals
and agency heads present in the auditorium and viewing
via satellite link, the conclusions of the Global Pheno-
type-Genotype Survey, GLOPS for short, a comprehen-
sive worldwide survey on phenotype-genotype and
microbiome individuality and exchange, carried out by a
coordinated consortium of essentially all international
accredited microbiome centres.
Just to re-cap: historically, it has been assumed that indi-
vidual human phenotypes were determined by individual
human genotypes, modulated in part by some environ-
mental factors. More recently, however, it has become
very evident that the microbiome – the microbial compo-
nent of the human biome – the microbes inhabiting all of
our external surfaces, including the GI tract, the airways
and urinary-genital tract and, occasionally, some internal
niches – contributes significantly to human phenotypes.
These contributions are additional to the well-known bat-
tery of microbial ecophysiological services to the human
host, such as assisting our digestion and releasing and
processing nutrients in our food intake, providing a range
of essential nutritional requirements we do not make or
acquire through our diets, protecting from infection, etc.,
etc. It is now clear that the microbiome has a pervasive
influence on our physical and, importantly, mental health
and individual behaviour29. The Grand Challenge for
microbiomologists, therefore, is to develop strategies
and mechanisms to optimize the compositions and func-
tions of our individual microbiomes for maximal health
benefits.
Moreover, in addition to the generic contributions the
microbiome makes to human biology, it has been found
that microbiomes harbour an enormous diversity of
microbes, and that everyone’s microbiome has a unique
composition – qualitatively and quantitatively30. A key
question this diversity triggers is: to what extent does
human individuality result from its microbiome
individuality?
ª 2018 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology., Microbial
Biotechnology, 12, 11–24
Editorial 13
The overarching goal of GLOPS was to identify which
microbes and microbial constellations have the greatest
impact on the health and well-being of human hosts, and
how these constellations and their influences are modi-
fied by host genetics, lifestyles and practices known or
suspected to actively mediate the sharing of micro-
biomes between individuals. It is the most ambitious sur-
vey ever conducted and I hope that its findings will
convince you that it brings us to both a better under-
standing of the relationship between human phenotypes
and their microbiomes, of parameters affecting micro-
biome composition, and how the microbiome may be
optimized for better health.





d Microbiome exchanges: to what extent are individual
differences influenced by sharing behaviours?
e Keystone microbes: which specific microbes and
microbial constellations seem to be keystone in the
determination of health- and well-being-related
parameters? and
f Keystone quality: among such keystone microbes
and microbial constellations, which seem to be partic-
ularly good at positively influencing such health
parameters?
GLOPS involved 173 designated centres in 69 countries
around the globe. Each centre recruited on average
1000 subjects, from which multiple, replicate dermal,
buccal, faecal and genital samples were collected on 4
occasions, that ultimately yielded 40m microbiota analy-
ses. All centres adopted identical protocols for subject
coding, acquisition of subject personal and clinical data,
data migration to our central database, patient stratifica-
tion, microbiome sampling, and DNA extraction-meta-
genome sequencing-sequence analysis.
An aliquot of every sample was stored locally. Once cor-
relations emerged, relevant sample aliquots were imme-
diately couriered to the Imaging Group of Mabriella
Golinari and Ranfredy Mohde of the Walpur Gisnacht
Institute for Cellular Pathology in Bad Hurzbarg in North-
ern Germany31, which is the leading group worldwide for
new microbe isolation and identification, and which was
responsible for keystone microbe isolation and
characterization.
Because this audience contains both specialists and
executives, I shall first provide an overall general
summary of the results, and then discuss the trial details
for the specialists, in order to allow the executives to
move on to other pressing issues.
To investigate the influence of sharing of microbiota, a
comprehensive spectrum of behavioural parameters
were queried, among which were:
• greetings, which ranged from no physical contact –
raised eyebrow32 faint nod and other bodily gestures,
vocal greeting, kiss blowing – to physical contact, rang-
ing from handshakes and variations thereof, hugs, 1/2/
3 kisses on the cheek/lips/feet, Hongi and variations
thereof, etc. (More intimate practices thought to exist in
a few cultures were not considered in this study.)
• sexual sharing of microbiota, frequency, diversity of
partners, body surfaces involved, number of partners
in each session, use of physical barriers to concep-
tion, use of toys, etc.
• non-sexual sharing microbiota practices, such as reg-
ular travel by bus, train, plane, sharing office space,
social gatherings such as parties, for couples sharing
a bed, the degree of body coverage by nightware, if
worn, relaxing in hot tubs, personnel caring for inca-
pacitated patients, etc. Potential subjects practicing
extreme physical contacts, like Sumo wrestlers,
safety-first teachers regularly practicing mouth-to-
mouth resuscitation, etc. were excluded from the
study.
• non-sexual sharing of microbiota mediated by house-
hold pets, using dogs as a proxy. The following cate-
gories of canine-mediated exchange of household
microbiota were considered (a) pet kept in a kennel
outside, (b) pet allowed in all rooms except kitchen
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and bedrooms, (c) dog allowed to sleep at the bottom
of the bed and lick faces of household members.
• non-biologically mediated mechanisms of sharing of
microbiota, categorized as households/places of work
being located close to waste treatment plants, densely
populated buildings lacking air exhaust filters, farm-
land frequently treated with pig slurry, parklands regu-
larly manicured with leaf blowers, etc.
The renowned mathematician, Professor Fidget Jones33,
served in this study as Deputy Coordinator, statistician
and modeller, was responsible for the GLOPS trial
design, defined subject and parameter stratifications,
evaluated the results, and developed predictive models.
He is with us today and I give the floor to him to summa-
rize the conclusions of the study. Fidget!
Professor Jones: Errrr, thank you Phichit. Well. . ..um-
mm. . ..given the complexity of the GLOPS study, the
even greater complexity of its results, the necessity for
development of entirely new algorithms to extract the
maximum information from the data and model it, and
the limited time at my disposal today, I will just summa-
rize the principle findings. These are:
1 every non-genetically-identical human has a unique per-
sonal biological phenotype profile or UBIP, which varies
significantly among individuals in terms of ecophysiology,
appearance, behaviour, personality, health robustness
and disease susceptibility, and ageing characteristics, a
unique genome, and a unique microbiome.
2 Certain components of the UBIP correlate strongly
with specific human genome features, and others cor-
relate strongly with specific microbiome features.
3 Specific features of human genomes correlate
strongly with specific features of microbiome compo-
sition34.
4 These findings suggest that the unique genome of
each and every one of us determines important ele-
ments of our microbiome composition. And, together,
our human genome and our microbiome genomes
determine a considerable number of our unique char-
acteristics, of our UBIP. In other words: who and what
we are the result of the integrated expression of our
human and microbiome genes. Put another way: the
metagenome of our biome largely determines our indi-
vidual biological phenotypes.
5 Some human characteristics seem to be strongly influ-
enced by individual microbial strains, raising the possi-
bility that there may exist certain keystone microbes
responsible for such characteristics.
These results are now in press and will appear next month
in Natural Science35. Of course, the conclusions I have pre-
sented are all tentative, since they are based on correlations,
but have allowed me to develop powerful new predictive
models that are the basis of the design of several human tri-
als involving microbiota exchanges to establish causalities.
These trials are well underway and their results can be
expected within the next 12 months.
I should now like to return the floor to Professor Dubbel-
blindangeentee, who will take us through the subject
selection process, the clinical assessments carried out,
the specific information queried in the trial, and the all-
important data security measures.
Fade out. . .. . .fade in Studio 7A.
Ms. Repor-Tastory: Yes: that was absolutely amazing at
the time!
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Dr. Noitall-Most: Indeed! We knew that our microbiomes
influence a number of health-related aspects but the magni-
tude and range of the influence on human characteristics
suggested by the survey was surprising. And now, one year
later, we have the results of the trials carried out to test the
predictions of the correlations found in the survey. The trials
have established a number of really interesting human char-
acteristics that are significantly influenced by our micro-
biome, and that are subject to modification by microbiota
changes. Amazingly, in some cases, specific individual
microbes were shown to act as keystone bugs27 influencing
specific human characteristics, which will significantly accel-
erate the translation of microbiome advances into medical
and commercial exploitation. However, tonight I will only dis-
cuss the general issue of microbiota exchanges, and return
to the specifics, in particular about which keystone microbes
control which phenotypes in future programmes.
Ms. Repor-Tastory: Fine Ani: we will look forward to
learning more about these fascinating findings.
Dr. Noitall-Most: So, as we might have anticipated, a key
microbiota sharing practice is physical intimacy36, so
succinctly encapsulated in the phase of the late, great
microbiologist Stanley Falkow: sex is simply the mixing
and matching of mucus membranes (which had in recent
years become more and more innovative), and so suc-
cinctly depicted in a cartoon he drew during one of his
classes for medical students, to illustrate person-to-per-
son disease transmission, shown here on the screen37
Of course, his famous comment focussed on sexually
transmitted infections, but his cartoon encapsulates the
modes of exchange of other mucosal microbes and,
indeed, non-mucosal microbes during human interac-
tions, sexual and non-sexual (e.g. food preparation and
sharing, aerosol sharing in confined spaces, pet sharing,
etc.). And of course, if microbiota exchanges through
such interactions so easily result in a dramatic pheno-
typic change, in the case of venereal disease, from a
healthy state to a rather uncomfortable, not to say some-
what embarrassing, disease state requiring medical
attention, it is to be expected that they can mediate other
phenotypic changes, not necessarily negative changes.
Ms. Repor-Tastory: Golly: our interactions with one
another, and with our pets, are a veritable microbial
stock exchange, with some acquisitions enhancing our
health wealth, and others causing health crises!
Dr. Noitall-Most: Yes, though unlike the normal variety of
stock exchange, we do not get to choose what we
receive.
However, Abi: one interesting peripheral finding of the
survey was directly relevant to our favourite mode of
relaxation. The Bad Hurzbarg Group managed to isolate
a bacterium from samples of people with a predilection
for G&T-time in the hot tub, but that was lacking from
non- or rare-hot tubbers. This bug has not been seen
before and thus a member of the rare biosphere38. Inter-
estingly, when given orally to humans that ordinarily do
not drink G&T and do not submerge themselves in hot
tubs, it induces a sense of well-being. Mab and Ran did
a metabolome study of this bug and found that it pro-
duces a chemical resembling a well-known relaxant.
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They called this bug Jacuzzia soporifico39, but hot tub
users immediately christened it Jacso. Apparently Jacso
forms biofilms, which are highly resistant to chlorine dis-
infectants, around the water:air interfaces of hot tubs
where they are orally acquired by G&T-drinking
occupants40.
Ms. Repor-Tastory, eagerly: Okay, Ani: but were key-
stone microbes determining human characteristics identi-
fied, and are the microbiomes of Adonis and Venus
better than those of Maude and Dennis?
Dr. Noitall-Most: Oh, indeed! But new discoveries con-
cerning phenotype-influencing microbiota and keystone
microbes will have to wait until the next show, because
we are running out of time. However, I will give a few
teasers to whet your and viewers’ appetites: let us say
that our vocal characteristics and several aspects of our
personal appearance and behaviour including, dare I say
it, libido, are all influenced by our microbiomes.
Ms. Repor-Tastory, with a can’t-wait-to-find-out look on
her face: oooohh: I think you’ll have to give me some
advance intelligence over a margarita after the pro-
gramme!
Dr. Noitall-Most: Of course, Abi! But to answer your
question about blue versus red blood: it turned out that
the microbiota of aristocrats are, on average, less
diverse and less potent at improving the biological prop-
erties tested than those of the hoi polloi, despite their
astonishingly high frequencies of microbiota sharing
activities among themselves. According to Professor Tim
Kennis of the Queenton Institute of Advanced Studies,
since the diversity of human genomes, and their pheno-
typic consequences – that is, the physiological differ-
ences between us – influence the composition of the
resident microbiomes, and since the resident micro-
biomes superimpose their own physiological modifica-
tions, there has been and still is co-evolution of the two
partners of the biome. His explanation is that, because
there is a greater level of interbreeding among blue
bloods, there is a lower level of human genetic diversity
and hence a lower degree of microbiome diversity. As a
result, the evolutionary speed of blue blood biomes is
slower, and they have less robust microbiomes. Exclu-
sivity comes at a cost. Of course, they have evolved to
compensate for the consequential less robust health by
taking breeding more seriously, which explains their
promiscuity.
Ms. Repor-Tastory, looking enlightened, and with
increased interest: Oh: that is the reason! And Maude
and Dennis have better microbiomes and better key-
stones; that is interesting!
Dr. Noitall-Most: Yes, but remember we are talking about
average microbiomes: I am quite sure that there are
some Adonis and Venus individuals with super micro-
biomes and super robust constitutions.
Ms. Repor-Tastory: Well, that is a relief!
Dr. Noitall-Most: I agree! But anyway, there was one par-
ticularly interesting finding relating to the microbiota of
aristocrats that I might mention at this juncture. It turns out
that the microbiota of the oral cavity of long pedigree aris-
tocrats contains several related microbes hardly found in
ordinary folk or in the nouveau riche, and which correlate
with the posh diction41 and sophisticated vocabulary of
blue bloods. Mab and Ran were not able to isolate these
and study them, so we have no evidence of causality, but
they were able to visualize these microbes in situ. They
were amorphous, non-descript bacteria belonging to a
new Candidate Division tentatively designated Exclusivia
inhabiting discrete regions of the epiglottis epithelial
sheet. They named them Aristodictionas plummyvowela
strains 1–4.
Ms. Repor-Tastory: What happens when they get trans-
ferred to ordinary folk during exploratory kissing?
Dr. Noitall-Most: Interesting question, Abi! It turns out
that only one of the A. plummyvowela strains has been
found in other folk, especially in socially upwardly mobile
people, who do articulate in a rather exaggerated man-
ner, as in Aive just bin down to the showroom and
ordered the new series 5 model.
Ms. Repor-Tastory: Yes, this funny way of speaking was
the basis of a number of sitcom comedies in the past.
Dr. Noitall-Most: In any case, there are some very inter-
esting findings about the microbiology of diction from the
GLOPS study, which we will deal with in a later
programme.
But all of this research is leading to some exciting devel-
opments in our understanding of the ramifications of
what sort of humans we are and how this is determined
by our microbial friends, on one hand, and the commer-
cial applications of this knowledge on the other. The
recognition that some of our features are determined or
influenced by individual microbes – keystone microbes –
and that both the keystone microbes and the microbiota
which play roles in our phenotypes vary in the magni-
tude of their influence – some are better than others –
has led to a number of economic assessments of the
commercial values of donor samples. This, in turn, has
spawned a plethora of secondary economic activities,
such as trading microbiota futures by brokers, insuring
own microbiota-microbiomes by those people in show
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business who habitually, very publically and for astro-
nomical sums insure their key show assets, holding
archived high value microbiota samples as investment
instruments, like old masters and fine wines, but also
growth in the whole public culture of microbiota applica-
tions and its aficionados, and faux-medical gurus (micro-
biota transplants have become next generation quinoa,
etc.). And of course the topic provides enormous copy
for newspapers and magazines, and career advance-
ment for agile reporters and analysts. There is even a
growing virtual currency – the mibithaler, or MBT –
based on the real donation of samples for archiving, their
virtual valuation, and use of the virtual values for trading
and saving.
Ms. Repor-Tastory: Well, I never! the financial ramifica-
tions of the microbiome world are evolving at an impossi-
ble speed. I heard that a number of companies
specializing in wellness products are aggressively mar-
keting transplant products of all sorts. Who on earth can
control the microbiome industry and ensure that micro-
biome technology is exploited safely?
Dr. Noitall-Most: Yes, Abi: there is, as you might expect,
a whole raft of legal, ethical and cultural issues and
uncertainties emerging from the business of microbiota
transplantation. One example is that some cultures,
while accepting the existence of the microbiome, do not
entertain its influence on the human entity – they believe
that all human characteristics are inherent – and have
banned the use and sale of transplant materials. Of
course, this has spawned a black market in such prod-
ucts controlled by black sheep. But of course, the illicit
trade in transplant samples is, like buying drugs on the
internet, fraught with risks of provenance and quality.
Indeed, some samples have been shown to consist only
of a poor quality flour. There are some black sheep out
there42!
Ms. Repor-Tastory: How interesting! And I recently read
somewhere that some philanthropic folk are donating
while alive, or willing after death, their microbiota sam-
ples to charities and other voluntary services.
Dr. Noitall-Most: Yes, Abi, and this brings us nicely to
the knotty issue of who owns, or at least shares with the
partner, what? One central component in the marriage
vows of traditional weddings is the commitment of all my
worldly goods I thee endow. This literally means the gift-
ing to the other partner of all personal resources. How-
ever, in modern weddings, the prenup has taken centre
stage because the average 5-year half-life of marriages
which precedes the inevitable 7-year itch, has had a
sobering influence on the perception of the partneristic
future. Previously, prenups were mostly concerned with
financial parameters of the involved partners, and the
biological baggage (children from previous partners fer-
ried into the new relationship). But now, instead of the
primary consideration being concerned with the past,
prenups are increasingly concerned with the future, in
particular to potential subsequent partner(s) and the evo-
lution of such relationships.
So, for example, does the I thee endow vow include
eggs of the female partner frozen, while pursuing a
career, for potential future fertilization, and sperm of the
male partner frozen to provide last gasp fertilization
options to perpetuate their lines?
Ms. Repor-Tastory: Gosh, yes: a central pillar of mar-
riage is the sharing eggs and sperms, so decisions
about what is permitted after a divorce with seed frozen
during a marriage is indeed a perplexing issue!
Dr. Noitall-Most: Exactly! But: the topic that concerns us
today is the increasing trend of young people to store
microbiota samples e.g., faecal microbiota, for possible
transplants at a later date, either for personal use or use
on others. So the issue is one of ownership and whether
or not the microbiomes become part of the goods I thee
endow. Moreover, since all microbiomes are not equal
and the ‘better’ ones have significant value, both to the
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other partner and as tangible commodities, things have
gone a step further and couples are attempting to assess
the value – personal and/or economic – of the partner’s
microbiome, prior to tying the knot. However, superim-
posed on all of this is the fundamental fact that marriage
precipitates comprehensive microbiota exchanges any-
way, so the issue of goods I thee endow is according to
some, entirely irrelevant with regard to the microbiome.
And then, of course, there is the uncomfortable issue of
infidelity which, in terms of microbiome sharing between
married couples, means the possibly unaware and almost
certainly unwanted sharing of third party microbiota.
Ms. Repor-Tastory: Golly: that is a thought – even worse
than the hot tub G&T sharing experience!
Dr. Noitall-Most: Absolutely! Of course all of this is a sort
of amusing topic for young couples thinking about the
great experiment of marriage, and may result in light-
hearted prenups.
Divorce is, however, a different matter and eggs, sperms
and microbiota samples become settlement assets for
lawyers to negotiate. So there is a vigorous discussion
taking place about modernizing the wedding vows to
incorporate the microbiome element.
While the whole business of marriage vows is currently
in a state of flux, there are several that are increasingly
adopted. These include:
A, will you take B to be your wife?
Will you love and comfort, honour and protect,
and, forsaking all others,
be faithful as long as you both shall live?
To have and to hold,
From this day forward,
For better for worse,
For richer for poorer,
In sickness and in health,
To love and to cherish,
To freely and selflessly share your reproductive
seeds and microbiomes,
So long as ye shall consider your partnership to have
a future,
After which ye shall consult a lawyer to divide in an
equitable manner all common assets.
The last line of this was, of course, written by a lawyer,
since, though legally logical, it is obvious to any microbi-
ologist that equitably dividing microbiomes is an abso-
lutely impossible task, thus providing a cause for
endless litigation, and the ultimate transfer of all con-
tested assets to the lawyer.
Ms. Repor-Tastory: Gosh, Ani: hasn’t the world become
philistine in recent years?
Dr. Noitall-Most: Yes, Abi, for sure! but here’s the thing
regarding marriage and microbiomes: if I am a biome,
consisting of a human and my integral microbiome, then
by definition the microbiome is a key stakeholder in all
actions that influence the future well-being of the biome.
Then: is it at all reasonable that the human part of me
unilaterally undertakes a serious commitment like mar-
riage, which involves long(ish) intimate physical interac-
tions with another biome, or should marriage be a
biome:biome contract? And, if so, how should my micro-
biome be consulted on the issue or, at least, its compati-
bility with the ‘other’ microbiome assessed?
Ms. Repor-Tastory: Golly: I had not thought about that! It
certainly bears thinking about. In the meantime, let us
return to the traditional ending to our programmes: are
there important applications of the discoveries we
learned about this evening?
Dr. Noitall-Most: Most certainly! Quite apart from the
non-microbiomological applications we have touched on
this evening, relating to legal aspects of ownership and
inheritance, there are some exciting new biomedical
applications currently being explored. One is very excit-
ing work initiated by Professor Vic Torde, Head of the
Lorenzo von Syntech High Security Institute for Artificial
Life in Madrid, who is applying synthetic microbiology to
reconfigure an important but so far confidential keystone
bacterium identified in the GLOPS study, which he calls
Synkey. He has two goals, the first of which is to design
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a very competitive version of Synkey able to establish
and maintain itself long-term in the gut, and that in addi-
tion to its normal keystone function, will serve as a ther-
apy delivery system for different metabolites that combat
diseases or increase well-being.
Ms. Repor-Tastory: Gosh: so the day of synthetic
microbes as therapies is drawing close!
Dr. Noitall-Most: Most certainly! Vic’s second goal is
even more ambitious. Thus far, attempts to restore nor-
mality to patients suffering from disease resulting from
dysbiosis involve microbiota transplants ranging from
faecal material to less complex mixtures and even sin-
gle microbes26. The problem is that complex mixtures
may be associated with significant risks and, in any
case, suffer from the challenges of standardization,
reproducibility and quality control, whereas single
strains are often ineffective at correcting dysbiosis situ-
ations. What Vic is doing is to use the camel nano-
body display approach43 to evolve a living scaffold for
the precision assembly of microbial consortia of an
exact, predetermined composition. In short, camel anti-
bodies that specifically bind to ligands/antigens present
on the surface of selected gut microbes essential for
restoring normality in a dysbiosis situation are dis-
played on the surface of Synkey. Mixing Synkey with
partner microbes displaying the appropriate natural or
engineered ligands/antigens results in a sort of click-
fastener joining and the formation of physically linked
partners in a precisely configured consortium, designed
to treat a specific dysbiosis44. And in collaboration with
immunologist partners, his group is designing Synkey
variants displaying nanobodies specific for host cells,
such as the gut-associated lymphoid tissue, in order to
target Synkey delivery systems to such tissues where
they can precisely stimulate desired immune
responses44.
Ms. Repor-Tastory: My goodness, whatever will synthetic
microbiology deliver next?
Dr. Noitall-Most: Aahhh: synthetic microbiologists are
indeed creative creatures! Another important application
is the explosion in demand for genome-metagenome
compatibility profiling in partner searches. A number of
partner search companies have teamed up with gen-
ome sequencing-storage-analysis companies and offer
phenotype-genotype profiling as part of their services.
Some even go as far as offering compatibility assess-
ment analyses/scores of offered partner options, but
received wisdom is that these are next to useless,
since most relationships are based on emotional chem-
istry which is, so far, not reliably interrogated through
metagenomics.
Ms. Repor-Tastory: Yes, I cannot imagine offering my
metagenome data to strangers, even a highly abstracted
form, and anyway, a candlelit dinner in a small, discrete
and preferably exclusive restaurant almost always
enables a good assessment of partnership potential.
Dr. Noitall-Most: And that, of course, is a key issue – the
one of security of such personal information, so that is
another major area of application, namely the develop-
ment of new encryption systems and firewalls for
metagenomic data storage facilities, which is occupying
quite a few microbial informaticians.
Ms. Repor-Tastory: well, viewers: on that note we end
this edition of ‘Discoveries that Change our Lives’. We
will be back next week with a follow-up edition to reveal
some more of the amazing findings of the GLOPS study
and its experimental follow-up.
As the camera pans away, viewers see Abi leaning
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